Will Soriot Ditch AstraZeneca In Favor Of Teva… And A $20m Bonus?

 
• By Lucie Ellis-Taitt

Pascal Soriot is reportedly about to abandon his top role at UK big pharma AstraZeneca to join Israel's generics giant Teva – a switch that could see him receive a $20m signing bonus, if the rumors are to be believed.

Pascal Soriot
Rumor Mill Is Whirring: AstraZeneca CEO Pascal Soriot Supposedly Proposition By Teva For Top Job • Source: Lucie Ellis

More from Leadership

More from Scrip